| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/3/264:01 PM | -$0.43 | -$0.64 | -48.8% | +14% | $20.8M | $17.8M | -14.7% | — | |
| Q2 '26 | 8/6/264:00 PM | -$0.57 | -$0.68GAAP | -19.3% | +6% | $2.0M | $3.6M | +77.2% | — | |
| Q1 '26 | 5/7/264:00 PM | -$0.71 | -$0.69GAAP | +2.8% | +12% | $3.8M | $0 | ⚠ Check | — | |
| Q4 '25 | 2/26/264:00 PM | -$0.75 | -$0.73GAAP | +2.7% | -9% | $9.0M | $0 | ⚠ Check | — | |
| Q3 '25 | 11/6/254:01 PM | -$0.76 | -$0.74GAAP | +2.6% | -17% | $6.2M | $0 | ⚠ Check | — | |
| Q2 '25 | 8/11/256:00 AM | -$0.74 | -$0.72GAAP | +2.7% | -22% | $13.4M | $0 | ⚠ Check | — | |
| Q1 '25 | 5/6/254:00 PM | -$0.71 | -$0.78GAAP | -9.9% | -15% | $3.2M | $0 | ⚠ Check | — |
⚠ Potential error in calculation, check manually. Reported revenue shows as zero, which usually means the figure is missing.
GAAP = diluted EPS as filed with the SEC. Other EPS figures are adjusted (non-GAAP), the basis analysts estimate.